Method of treating inflammation with antibodies to neutrophil chemotactic factor

US5925352A · kind A · utility

Assignee

• The United States of America, as represented by the Department of Health and Human Services · US

Inventors

• Kouji Matsushima · Matsudo, JP
• Teizo Yoshimura · Frederick, US
• Edward J. Leonard · Bethesda, US
• Joost Oppenheim · Bethesda, US
• Ettore Appella · Bethesda, US
• Stephen D. Showalter · Frederick, US

Key dates

• Filing date: Sep 23, 1997
• Grant date: Jul 20, 1999
• Expiry date: Sep 23, 2017

Classification

• Technology area (CPC Y): Emerging Cross-Sectional Technologies
• CPC primary: Y10S930/12
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

An isloated, synthetic preparation of a novel neutrophil-specific chemotactic factor (NCF), monoclonal antibodies having specific binding affinity for NCF and a clone containing the complete cDNA coding sequence for NCF are disclosed.